Growth Metrics

Uxin (UXIN) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Uxin (UXIN) over the last 8 years, with Q3 2025 value amounting to $813327.0.

  • Uxin's Cost of Revenue rose 7590.77% to $813327.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $228.6 million, marking a year-over-year decrease of 9999.88%. This contributed to the annual value of $231.7 million for FY2024, which is N/A changed from last year.
  • Uxin's Cost of Revenue amounted to $813327.0 in Q3 2025, which was up 7590.77% from $87.1 million recorded in Q2 2025.
  • Uxin's 5-year Cost of Revenue high stood at $266689.0 billion for Q2 2021, and its period low was $0.3 during Q1 2024.
  • For the 5-year period, Uxin's Cost of Revenue averaged around $15039.0 billion, with its median value being $485805.0 (2021).
  • In the last 5 years, Uxin's Cost of Revenue plummeted by 10000.0% in 2022 and then soared by 2167462226967.02% in 2025.
  • Quarter analysis of 5 years shows Uxin's Cost of Revenue stood at $485805.0 in 2021, then dropped by 3.73% to $467676.0 in 2022, then dropped by 16.47% to $390638.0 in 2023, then skyrocketed by 19359.19% to $76.0 million in 2024, then crashed by 98.93% to $813327.0 in 2025.
  • Its last three reported values are $813327.0 in Q3 2025, $87.1 million for Q2 2025, and $64.6 million during Q1 2025.